# The Efficacy of Incobotulinum Toxin A Injections for Treatment of Tinnitus: a Randomized Controlled Trial

> **NCT05650645** · PHASE2 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 41 (actual)

## Conditions studied

- Tinnitus

## Interventions

- **DRUG:** incobotulinum toxin A
- **DRUG:** Placebo-Saline

## Key facts

- **NCT ID:** NCT05650645
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2025-12-29
- **Final completion:** 2025-12-29
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05650645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05650645, "The Efficacy of Incobotulinum Toxin A Injections for Treatment of Tinnitus: a Randomized Controlled Trial". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT05650645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*